Evopoint Biosciences to Debut on STAR Market in Mid-September

Stock News

昨天

Evopoint Biosciences Co., Ltd. (stock code: 688837.SH) has confirmed its highly anticipated listing on the Science and Technology Innovation Board of the Shanghai Stock Exchange, with trading slated to commence on September 16, 2026.

The company's official announcement confirms this milestone, marking a significant step for the biopharmaceutical firm as it enters the capital markets arena.

This initial public offering will allow the company to leverage the STAR Market's focus on innovative and high-growth technology enterprises, providing a platform for its future development and expansion initiatives. Investors will now be able to trade shares of Evopoint Biosciences Co., Ltd. (688837.SH) as of the specified date.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1188955438"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1188955438\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1188955438?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-14 21:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188955438","market":"sh","top_or_hot":-1,"title":"Evopoint Biosciences to Debut on STAR Market in Mid-September","media":"Stock News","content":"<p><b>Evopoint Biosciences Co., Ltd.</b> (stock code: 688837.SH) has confirmed its highly anticipated listing on the Science and Technology Innovation Board of the Shanghai Stock Exchange, with trading slated to commence on September 16, 2026.<br><br>The company's official announcement confirms this milestone, marking a significant step for the biopharmaceutical firm as it enters the capital markets arena.<br><br>This initial public offering will allow the company to leverage the STAR Market's focus on innovative and high-growth technology enterprises, providing a platform for its future development and expansion initiatives. Investors will now be able to trade shares of <b>Evopoint Biosciences Co., Ltd.</b> (688837.SH) as of the specified date.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Evopoint Biosciences to Debut on STAR Market in Mid-September</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEvopoint Biosciences to Debut on STAR Market in Mid-September\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-09-14 21:36</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><b>Evopoint Biosciences Co., Ltd.</b> (stock code: 688837.SH) has confirmed its highly anticipated listing on the Science and Technology Innovation Board of the Shanghai Stock Exchange, with trading slated to commence on September 16, 2026.<br><br>The company's official announcement confirms this milestone, marking a significant step for the biopharmaceutical firm as it enters the capital markets arena.<br><br>This initial public offering will allow the company to leverage the STAR Market's focus on innovative and high-growth technology enterprises, providing a platform for its future development and expansion initiatives. Investors will now be able to trade shares of <b>Evopoint Biosciences Co., Ltd.</b> (688837.SH) as of the specified date.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KSTR","symbol_name":"中國科技半導體科創50指數ETF-KraneShares","start_time":0,"source_url":"","article_id":"1188955438","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188955438","pubTimestamp":1789392975,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Evopoint Biosciences Co., Ltd. (stock code: 688837.SH) has confirmed its highly anticipated listing on the Science and Technology Innovation Board of the Shanghai Stock Exchange, with trading slated...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688837":"信诺维-U","KSTR":"中国科技半导体科创50指数ETF-KraneShares","IPOS":"Renaissance International IPO ETF"},"translate_title":"Evopoint Biosciences 将于 9 月中旬在科创板上市","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688837":1,"IPOS":1,"KSTR":1},"content_text":"Evopoint Biosciences Co., Ltd. (stock code: 688837.SH) has confirmed its highly anticipated listing on the Science and Technology Innovation Board of the Shanghai Stock Exchange, with trading slated to commence on September 16, 2026.The company's official announcement confirms this milestone, marking a significant step for the biopharmaceutical firm as it enters the capital markets arena.This initial public offering will allow the company to leverage the STAR Market's focus on innovative and high-growth technology enterprises, providing a platform for its future development and expansion initiatives. Investors will now be able to trade shares of Evopoint Biosciences Co., Ltd. (688837.SH) as of the specified date.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}